These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2419766)

  • 1. Biotechnology. All systems go in Britain.
    Newmark P
    Nature; 1986 Mar 13-19; 320(6058):100. PubMed ID: 2419766
    [No Abstract]   [Full Text] [Related]  

  • 2. TPA patent battle rages in United Kingdom.
    Johnston K
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671
    [No Abstract]   [Full Text] [Related]  

  • 3. Claims on tissue plasminogen activator.
    Crespi RS
    Nature; 1989 Jan; 337(6205):317-8. PubMed ID: 2492089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPA patent battle continues in court.
    Johnston K
    Nature; 1987 Jun 18-24; 327(6123):546. PubMed ID: 3110620
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteplase (rtPA) patent case.
    Brahams D
    Lancet; 1988 Nov; 2(8622):1263. PubMed ID: 2904002
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotechnology: interferon patent contested.
    Earl C; Beardsley T
    Nature; 1984 Mar 1-7; 308(5954):7. PubMed ID: 6199674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotechnology patents. Genentech wins round two.
    Gershon D
    Nature; 1990 Apr; 344(6268):692. PubMed ID: 2109830
    [No Abstract]   [Full Text] [Related]  

  • 9. Genentech patent.
    Nature; 1988 Sep; 335(6186):105. PubMed ID: 3137476
    [No Abstract]   [Full Text] [Related]  

  • 10. New battle over TPA.
    Ezzell C
    Nature; 1989 Aug; 340(6233):418. PubMed ID: 2502715
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality control of rDNA-derived human tissue-type plasminogen activator.
    Jones AJ; Garnick RL
    Bioprocess Technol; 1990; 10():543-66. PubMed ID: 1367501
    [No Abstract]   [Full Text] [Related]  

  • 12. Wellcome versus Genentech result.
    Johnston K
    Nature; 1987 Jul 16-22; 328(6127):189. PubMed ID: 3110626
    [No Abstract]   [Full Text] [Related]  

  • 13. Boehringer Mannheim's new clot buster.
    Nat Biotechnol; 1997 Feb; 15(2):114. PubMed ID: 9035121
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-examination ends in TPA patent case.
    Newmark P
    Nature; 1987 Jun 25-Jul 1; 327(6124):650. PubMed ID: 3110622
    [No Abstract]   [Full Text] [Related]  

  • 15. Ruling on heart drug may boost research.
    Sun M
    Science; 1987 Jul; 237(4812):244. PubMed ID: 3110951
    [No Abstract]   [Full Text] [Related]  

  • 16. Companies vie over new heart drug.
    Sun M
    Science; 1987 Jul; 237(4811):120-2. PubMed ID: 3110949
    [No Abstract]   [Full Text] [Related]  

  • 17. Genentech loses appeal against Wellcome.
    McGourty C
    Nature; 1988 Nov; 336(6194):4. PubMed ID: 3141815
    [No Abstract]   [Full Text] [Related]  

  • 18. Competition in the marketplace. t-PA trials, tribulations, and litigation.
    Ratner M
    Biotechnology (N Y); 1990 May; 8(5):385, 387. PubMed ID: 1367434
    [No Abstract]   [Full Text] [Related]  

  • 19. British ruling supports legal challenge to broad patents.
    Dickson D
    Nature; 1996 Nov; 384(6604):7. PubMed ID: 8900258
    [No Abstract]   [Full Text] [Related]  

  • 20. Affymetrix license valid, rules court.
    Robertson D
    Nat Biotechnol; 2001 Jan; 19(1):13-4. PubMed ID: 11135539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.